>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • SPAN +35.3%, (thinly traded), LMNX +20%, MOC +16.9%, CHGG +14.6%,THC +13.9%, IAC +10.2%, CORT +9.1%, TXRH +8.7%, HLTH +8.1%, APTS +7.9%, IPGP +6.6%, ECA +6.5%, INST +6.3%, COH +6.1%, CMI +5.8%, EXEL +4.9%, DAN +4.2%, FLT +4%, (also to acquire Cambridge Global Payments for approximately $675 mln; expected to be immediately accretive to earnings upon closing), CYH +3.4%, (also to sell Tomball and Jourdanton, Texas Hospitals to HCA), BWEN +3.4%, CC +3.1%, GBT +2.9%, IIVI +2.9%,MLM +2.8%, NBL +2.2%, RCII +2.2%, (also mails definitive proxy materials for June 8 meeting), EIGI +2%, ETN +2%, SHPG +1.9%, RYAM +1.8%, EPD +1.8%, CVS +1.6%, BP +1.5%, VSM +1.5%, MA +1.4%, FLS +1.3%, WLK +1.3%, HLT +1.1%, WEC +1.1%, SQNS +0.9%, IVAC +0.8%, EMR +0.7%, PBI +0.7%
M&A news:
  • ANGI +55% (Angie's List and IAC confirm HomeAdvisor to combine with Angie's List; Angie's List stockholders will have the right to elect to receive one share of Class A common stock of ANGI Homeservices or $8.50 per share in cash)
    • IAC +10.9%
  • NBL +2.2% ( to divest all of its upstream assets in northern West Virginia and southern Pennsylvania to an undisclosed buyer for a total amount of $1.225 billion), .
Other news:
  • BDSI +20% (obtains FDA approval of a sNDA for BUNAVAIL buccal film revising the indication to include the use of BUNAVAIL)
  • TNXP +5.9% (ssuance of a patent for the composition and manufacture of a unique formulation that characterizes TNX-102 SL)
  • LMAT +2.7% (LeMaitre Vascular Inc. (LMAT) will replace First NBC Bank Holding in the S&P SmallCap 600 effective prior to the open on Wednesday, May 3)
  • SSL +1.6% (reports 9-month production)
  • FMSA +1.2% (Point72 Asset Management increases passive stake)
  • RTN +1% (ticking higher; awarded a $327,146,998 Navy contract)
  • OREX +1% (announces commercialization of Mysimba; signs Distributorship Arrangement with Navamedic ASA)
Analyst comments:
  • DFT +1.1% (upgraded to Overweight at KeyBanc Capital Mkts)

>>> AB Inbev - Interesting Chart configuration

* Stock is trading today above its 200d MA - first time since Nov 2016
* Stock has underperfomed SX5E by 3.9% YTD / by 16.80% on 52w., Underperformed SX3E by another 3%
* Beverage continue to Underperform the broader market but communications from integration & Synergies from SAB Deal could help the performance
* 2017 Highs have been tested and broken today (103.12 - we traded up to 103.20)
* Stock opened with a gap today ( 101.82/102.80) if they close above the 200d MA (102.30) could see an acceleration to check higher levels
* 106.87 (3.8% higher) is the first level we should check on the upside - with an extension the 108 levels
* Support is the 50d MA (100.84) and the bottom of the range where we trade 100.34.
* Stock is trading Ex Div today and Reporting on Thu. 4th of May.

I will buy the stock to play a bounce from here.

See a quick chart below :

>>> Sabre beats by $0.07, beats on revs; reaffirms FY17 EPS guidance, revs guid

Sabre beats by $0.07, beats on revs; reaffirms FY17 EPS guidance, revs guidance (23.63)
  • Reports Q1 (Mar) earnings of $0.42 per share, excluding non-recurring items, $0.07 better than the Capital IQ Consensus of $0.35; revenues rose 6.5% year/year to $915.35 mln vs the $897.62 mln Capital IQ Consensus.
  • Co reaffirms guidance for FY17, sees EPS of $1.31-1.45, excluding non-recurring items, vs. $1.37 Capital IQ Consensus Estimate; sees FY17 revs of $3.54-3.62 bln vs. $3.57 bln Capital IQ Consensus Estimate.
  • "We are off to a solid start on the year with good revenue growth across the business. The macro global travel environment was supportive of growth in travel and helped drive strong bookings, passengers boarded and hotel transaction growth across our businesses in the quarter," said Sean Menke, Sabre president and CEO. "For the first quarter, Airline and Hospitality Solutions revenue grew 8.2%, supported by 7.1% growth in passengers boarded and a strong increase in hotel transactions. Travel Network revenue increased 6.1% supported by robust bookings in all major regions of the world.

WWD : Deal Options for Coach, Kate Spade Seen Broadening

Deal Options for Coach, Kate Spade Seen Broadening
The Kate Spade team is believed to have now reached out to private equity firms in its efforts to sell the company.

When Coach Inc. turns in its fiscal third-quarter results today, analysts will be watching for any indication that it might still be interested in Kate Spade & Co. — or if it is now looking further afield and perhaps to the recently available Bally or Jimmy Choo.

And if Coach has indeed moved on after extensive talks with Kate Spade, it might help push the quirky handbag company toward private equity players.

Financial sources told WWD that private equity firms are taking a second look at Kate Spade and that a dialogue with the company has begun, furthering the credence that talks between Coach and Kate Spade have stalled. One source said Kate is “committed to selling itself.”

A spokeswoman for Kate Spade declined to comment on the firm’s outreach to private equity firms.

Earlier this year, sources said private equity companies had looked at the Kate Spade brand, but really couldn’t get any traction in a process focused on finding a strategic buyer that was likely to pay more.

But Coach is said to have put in a low offer and Michael Kors Holdings, a competitor in the so-called handbag wars, has had discussions with Kate Spade but has largely sat on the sidelines. Sources said Kors remains “interested” in Kate Spade, but hasn’t put any bid on the table.

Sources said the talks between Coach and Kate Spade stalled about two to three weeks ago. And Kate Spade’s lackluster first-quarter earnings report last month showed it had more work to do in its North American business, making it harder for the firm to get a big premium in a deal. Moreover, Coach’s chief executive officer Victor Luis has previously said he wasn’t interested in a “turnaround” situation, leading to speculation that maybe the group was no longer interested in Kate Spade.

And Coach would seem to have a growing list of options as well as a sizable war chest to do a deal.

According to Wolfe Research’s Adrienne Yih, Coach has a net cash position of $1.24 billion, comprised of $1.84 billion in cash and $592 million in debt. She expects the above-$400 price point handbag penetration to be nearly 60 percent for the third quarter. Wall Street’s consensus estimate for the third quarter pegs diluted earnings per share of 44 cents on net sales of $1.02 billion.

The options of brands for Coach to acquire also have lengthened following the news last month that JAB Holding Co. is looking to sell Bally and Jimmy Choo.

Luis has said Coach is looking at acquisitions to transform itself into a holding company of brands. But whether it wants to go the luxury-aspirational route or remain focused on just high-end luxury remains unclear. An acquisition of Kate Spade would move it in the luxury-aspirational direction, capturing the luxury consumer with Coach’s 1941 Collection and building out the aspirational category with its own core mass luxury line and the Kate Spade brand, popular among Millennial women.

Should Coach want to be the American counterpart to a LVMH Moët Hennessy Louis Vuitton or Kering, then clearly Bally and Jimmy Choo would make for better “luxury” acquisition targets. Financial sources over the past few days said they believe Coach is aiming for the luxury market. Bally would fit the bill because it does both men’s and women’s, in footwear, accessories and outerwear — Luis has told WWD that Coach would be interested in acquiring brands that do business in these categories. And Coach has the sourcing capability for all three categories, a big consideration for any deal, Luis has said.

Choo would represent a footwear brand that is a notch up from Stuart Weitzman, which Coach acquired in May 2015 for $574 million. There’s been much speculation that Coach could bid for Choo given that Josh Schulman, who joined the accessories firm as president and ceo of the Coach brand, was once ceo of Choo.

A spokeswoman for Coach declined comment on speculative reports that the company was eyeing targets other than Kate Spade.

Cowen & Co.’s Oliver Chen last Wednesday in a research note had an “0utperform” rating on Coach shares, with a price target of $40. He said the sale of Choo “adds another attractive and synergistic target for Coach to pursue.” The analyst noted Choo’s market cap at $952 million.

Shares of Coach on Monday fell 1.7 percent to close at $38.74 in Big Board trading.

>>> US Early premarket gappers

Early premarket gappers
Gapping up:
  • ANGI +41.8%, SPAN +35.3%, LMNX +16.2%, THC +15.7%, CHGG +13%,CORT +9.1%, TXRH +8.7%, APTS +7.9%, INST +6.3%, IAC +5.8%, EXEL+5.8%, IAC +5.8%, AMAG +5.5%, ECA +4.9%, FLT +4%, CYH +3.4%, IIVI+2.9%, LMAT +2.7%, SHOP +2.3%, NBL +2.2%, RCII +2.2%, CC +2%, EIGI+2%, ETN +2%, SHPG +2%, RYAM +1.8%, BP +1.5%, MRK +1.5%, VSM +1.5%,FLS +1.3%, FMSA +1.2%, GBT +1.1%, HLT +1.1%, WEC +1.1%, IVAC +0.8%,PBI +0.7%
Gapping down:
  • CGI -31.3%, HLIT -19%, SNSS -18%, MEDP -13.4%, AMD -12.3%, BLDP-5.4%, CUTR -3.7%, AEIS -3.5%, APU -3.5%, TMHC -3.3%, AGNC -3.3%,EMR -3.1%, TBI -2.9%, COP -2.9%, NYLD -2.9%, HCLP -2.8%, ZIOP -2.5%,LL -2.2%, MOS -1.9%, CGNX -1.3%, ARR -1.3%, MO -1.3%, KR -1.2%, AGLE-0.9%, LYB -0.9%

>>> Mosaic misses by $0.16, misses on revs; reaffirms FY17 outlook

Mosaic misses by $0.16, misses on revs; reaffirms FY17 outlook
  • Reports Q1 (Mar) earnings of $0.04 per share, excluding non-recurring items, $0.16 worse than the Capital IQ Consensus of $0.20; revenues fell 5.7% year/year to $1.58 bln vs the $1.68 bln Capital IQ Consensus.
Outback for Q2:
  • Total sales volumes for the Phosphates segment are expected to range from 2.3 to 2.6 million tonnes for the second quarter of 2017, compared to 2.4 million tonnes last year. Mosaic's realized DAP price, FOB plant, is estimated to range from $320 to $340 per tonne for the second quarter of 2017.
  • Total sales volumes for the Potash segment are expected to range from 2.0 to 2.3 million tonnes for the second quarter of 2017, compared to 2.0 million tonnes last year. Mosaic's realized MOP price, FOB plant, is estimated to range from $170 to $185 per tonne.
  • Total sales volumes for the International Distribution segment are expected to range from 1.4 to 1.7 million tonnes for the second quarter of 2017, compared to 1.4 million tonnes last year. The segment gross margin per tonne is estimated to be approximately $20.
Full year estimates remain unchanged. Mosaic estimates:
  • Phosphates sales volumes in the range of 9.5 to 10.25 million tonnes.
  • Potash sales volumes in the range of 8.0 to 8.75 million tonnes.
  • International Distribution sales volumes in the range of 7.0 to 7.5 million tonnes.

>>> Coach beats by $0.02, misses on revs; reaffirms 2017 guidance

Coach beats by $0.02, misses on revs; reaffirms 2017 guidance
  • Reports Q3 (Mar) earnings of $0.46 per share, $0.02 better than the Capital IQ Consensus of $0.44; revenues fell 3.7% year/year to $995.2 mln vs the $1.02 bln Capital IQ Consensus.
    • As planned, the Company's strategic decision to elevate the Coach brand's positioning in the North American wholesale channel through a reduction in promotional events and door closures negatively impacted sales growth by approximately 150 basis points in the quarter.
    • Gross margin for the quarter expanded 190 basis points from prior year to 70.9% on both a reported and non-GAAP basis.
  • Reaffirms 2017 guidance:
    • Continues to expect revenues for fiscal 2017 to increase low-single digits, including the impact of currency (Consensus represents +1% rev growth expectation).
    • Continues to project double-digit growth in both net income and earnings per diluted share for the year (Consensus represents +8% EPS growth expectation)
    • Maintaining operating margin forecast for Coach, Inc. of between 18.5-19.0% for fiscal 2017. This guidance incorporates the negative impact of both Stuart Weitzman and the strategic decision to elevate the Coach brand's positioning in the North American wholesale channel, including a reduction in promotional events and the closure of about 25% of doors.
    • Interest expense is now expected to be in the area of $20 million for the year while the full year fiscal 2017 tax rate is still projected at about 26%.

>>> Altria misses by $0.01, reports revs in-line; guides FY17 EPS in-line (70.8

Altria misses by $0.01, reports revs in-line; guides FY17 EPS in-line (70.80)
  • Reports Q1 (Mar) earnings of $0.73 per share, $0.01 worse than the Capital IQ Consensus of $0.74; revenues rose 1.3% year/year to $4.59 bln vs the $4.63 bln Capital IQ Consensus.
  • Co issues in-line guidance for FY17, sees EPS of $3.26-3.32 vs. $3.29 Capital IQ Consensus Estimate. Altria continues to expect higher adjusted diluted EPS growth in the second half of the year compared to the first half driven by various factors. These include the financial effects of the Recall during the first quarter of 2017 and the benefit of reporting four full quarters of equity income from Altria's beer investment in 2017 versus three quarters in 2016.
  • "We grew first-quarter adjusted diluted earnings per share by 1.4% against a difficult comparison in the year-ago quarter when we grew adjusted diluted EPS more than 14%. The smokeable products segment continued to generate strong results, which offset lower equity earnings from our beer investment and the effect of the voluntary product recall in the smokeless products segment.

>>> ConocoPhillips misses by $0.05

ConocoPhillips misses by $0.05 (47.48)
  • Reports Q1 (Mar) loss of $0.02 per share, excluding non-recurring items, $0.05 worse than the Capital IQ Consensus of $0.03.
    • Reported first-quarter 2017 earnings of $0.8 billion, or $0.62 per share, compared with a first-quarter 2016 loss of $1.5 billion, or ($1.18) per share. Excluding special items, first-quarter 2017 adjusted earnings were a loss of $19 million, or ($0.02) per share, compared with a first-quarter 2016 adjusted loss of $1.2 billion, or ($0.95) per share. Special items for the current quarter were primarily driven by a financial tax accounting benefit related to the previously announced Canadian disposition, partially offset by a non-cash impairment in Alaska.
  • Production excluding Libya for the first quarter of 2017 was 1,584 thousand barrels of oil equivalent per day (MBOED), an increase of 6 MBOED compared with the same period a year ago. The increase was the result of production ramping up from several major projects, multiple development programs and improved well performance, partly offset by normal field decline and dispositions. Excluding the net impact from dispositions of 36 MBOED and reduced downtime of 18 MBOED, production increased 24 MBOED, or 2 percent.
  • Q2 Production Outlook
    • Second-quarter 2017 production is expected to be 1,495 to 1,535 MBOED, which excludes Libya and does not reflect impacts from the recently announced Canada and San Juan Basin dispositions.

>>> Shire plc beats by $0.34, reports revs in-line; reaffirms FY17 EPS guidance,

Shire plc beats by $0.34, reports revs in-line; reaffirms FY17 EPS guidance, revs guidance (176.47)
  • Reports Q1 (Mar) earnings of $3.63 per share, excluding non-recurring items, $0.34 better than the Capital IQ Consensus of $3.29; revenues rose 109.0% year/year to $3.57 bln vs the $3.54 bln Capital IQ Consensus.
  • Co reaffirms guidance for FY17, sees EPS of $14.60-15.20 vs. $15.00 Capital IQ Consensus Estimate; sees FY17 revs of $14.5-14.8 bln vs. $15.23 bln Capital IQ Consensus Estimate.
  • SHP643 for the treatment of HAE. The SHP643 open-label extension study completed enrollment in March 2017. Topline pivotal Phase 3 study results are expected in Q2 2017. SHP640 for the treatment of bacterial and adenoviral conjunctivitis. The global Phase 3 clinical development program will have clinical sites in over 20 countries. Patient recruitment has started and the first patient visit occurred in March 2017. The topline data is expected in Q2 2018.